Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000912057-01-006691
Filing Date
2001-02-26
Accepted
2001-02-26 00:00:00
Documents
8
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2039996z10-k.txt 10-K 349592
2 EXHIBIT 10.91 a2039996zex-10_91.txt EX-10.91 14119
3 EXHIBIT 10.92 a2039996zex-10_92.txt EX-10.92 23000
4 EXHIBIT 10.93 a2039996zex-10_93.txt EX-10.93 4625
5 EXHIBIT 10.94 a2039996zex-10_94.txt EX-10.94 74931
6 EXHIBIT 10.95 a2039996zex-10_95.txt EX-10.95 2703
7 EXHIBIT 11.1 a2039996zex-11_1.txt EX-11.1 1681
8 EXHIBIT 23.1 a2039996zex-23_1.txt EX-23.1 593
  Complete submission text file 0000912057-01-006691.txt   473595
Mailing Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707
Business Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707 9194935980
TRIANGLE PHARMACEUTICALS INC (Filer) CIK: 0001022622 (see all company filings)

EIN.: 561930728 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21589 | Film No.: 1554511
SIC: 2834 Pharmaceutical Preparations